Opioid Industry Bankruptcies

Gilbert’s work to combat the opioid crisis extends to the bankruptcy arena.

In 2019, Gilbert was appointed by the U.S. Bankruptcy Court for the Southern District of New York as mass tort, deal, and insurance counsel to the ad hoc committee of supporting governmental entities in In re: Purdue Pharma L.P., the bankruptcy proceedings arising out of Purdue’s role in contributing to the opioid crisis.

Most recently, following significant analysis of the insurance available to Purdue Pharma L.P., Gilbert LLP and other firms have filed the largest insurance coverage action filed to date concerning opioids (now pending in the United States Bankruptcy Court for the Southern District of New York).

In 2020, Gilbert was similarly retained by the ad hoc committee of governmental plaintiffs in In re: Mallinckrodt PLC, the bankruptcy proceedings arising out of Mallinckrodt’s role in contributing to the opioid crisis. Gilbert’s work in both bankruptcies builds on its decades of experience working on major corporate bankruptcies predicated by mass tort liabilities.

The Purdue and Mallinckrodt bankruptcies are two of several opioid matters in which Gilbert is involved, including the MDL proceedings in Ohio and litigations by state attorneys general and sovereign Indian tribes against opioid manufacturers, distributors, chain retailers, and others seeking remediation and damages for the U.S. opioid crisis.